MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 71,581 Shares of Bioceres Crop Solutions Corp. $BIOX

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) by 9.5% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 823,916 shares of the company’s stock after acquiring an additional 71,581 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned approximately 1.31% of Bioceres Crop Solutions worth $3,761,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of BIOX. Bank of America Corp DE grew its holdings in Bioceres Crop Solutions by 186.8% during the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after purchasing an additional 3,735 shares during the period. Avanza Fonder AB bought a new stake in Bioceres Crop Solutions during the first quarter valued at about $72,000. PDT Partners LLC bought a new stake in Bioceres Crop Solutions during the first quarter valued at about $81,000. Northern Trust Corp bought a new stake in Bioceres Crop Solutions during the fourth quarter valued at about $93,000. Finally, Walleye Capital LLC bought a new stake in Bioceres Crop Solutions during the first quarter valued at about $199,000. Institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Stock Down 2.4%

Shares of NASDAQ:BIOX opened at $2.04 on Friday. The company has a 50-day moving average price of $3.26 and a 200 day moving average price of $4.08. The company has a market cap of $127.93 million, a price-to-earnings ratio of -2.52, a PEG ratio of 0.89 and a beta of 0.43. The company has a current ratio of 1.02, a quick ratio of 0.74 and a debt-to-equity ratio of 0.22. Bioceres Crop Solutions Corp. has a 12 month low of $1.97 and a 12 month high of $8.93.

Analysts Set New Price Targets

Several research firms have issued reports on BIOX. Lake Street Capital cut their price target on Bioceres Crop Solutions from $8.00 to $5.00 and set a “buy” rating for the company in a report on Wednesday. Wall Street Zen cut Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a report on Saturday. Brookline Capital Management cut Bioceres Crop Solutions from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 21st. Canaccord Genuity Group reissued a “hold” rating and set a $2.50 price target (down from $6.50) on shares of Bioceres Crop Solutions in a report on Wednesday. Finally, Oppenheimer set a $5.00 price target on Bioceres Crop Solutions in a report on Tuesday. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $4.17.

Bioceres Crop Solutions Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.